Autoimmune disease drug developer Pandion Therapeutics closed a series B round co-led by Access Biotechnology and backed by Roche Venture Fund and SR One.

The Parkinson's disease therapy developer closed the series A funding less than four months after a Eurofarma-backed seed round.

Based on research at Grousbeck Gene Therapy Center and Massachusetts Eye and Ear, Affinia has raised $60m in a series A round to advance its gene therapies into the clinic.

Lonza participated in the gene therapy developer's series A round alongside Partners Innovation Fund, having also licensed technology to the startup.

General Catalyst led a $51m round for the Ascension-backed healthcare automation technology developer, which has now received $119m in total.

Bpifrance supplied funding through three separate units to help take Satt Conectus-allied rare disease drug developer Dynacure's latest round to $55m.

58.com and its 58 Aifang subsidiary invested $70.5m and will help the online real estate marketplace expand its services and grow throughout southwestern China.

Cethik-backed artificial intelligence chipmaker NextVPU has received $42.3m from unnamed investors to scale its research and development activities.

The corporate-backed mobile banking services provider collected $43.6m in a round co-led by Goodwater Capital and Greenspring Associates.

SoftBank China Venture Capital returned for a $42.3m round that will support the international growth of Huilianyi's expenses management software.